Many stakeholders and steps are involved in the life cycle of a prescription drug as it moves from chemical synthesis and formulation through dispensing or administration to patients. The specific steps involved in prescription drug supply chains often differ depending on the type of drug, the channel of distribution, and the patient’s source of prescription drug coverage.
Report
Reports
Displaying 111 - 120 of 245. 10 per page. Page 12.
Advanced SearchReport
Medical Device Supply Chains: An Overview and Description of Challenges During the COVID-19 Pandemic
This report provides an introduction to the supply chain for COVID-19 relevant medical devices and related challenges faced in ramping up their production during the COVID-19 pandemic.
Report
Assessing Relationships between Drug Shortages in the United States and Other Countries
Drug shortages are a persistent public health problem in the United States and in other countries. Shortages can have important implications for the health care systems and pharmacies that purchase, store, and dispense drugs and for the patients who rely on the availability of drugs to treat and prevent disease.
Report
Considerations for Building Federal Data Capacity for Patient-Centered Outcomes Research Related to Intellectual and Developmental Disabilities
This report describes the current state of Patient-Centered Outcomes Research (PCOR) data infrastructure resources related to Intellectual and Developmental Disabilities (ID/DD), highlights data issues in the ID/DD research landscape that require more research, and identifies opportunities to enhance data infrastructure to improve PCOR for ID/DD.
Related Products:
Report
Guidelines for Regulatory Impact Analysis Supplement: Addressing International Effects
This report extends the brief discussion of addressing international effects contained in the Department of Health and Human Service Guidelines for Regulatory Impact Analysis (2016). The purpose of this supplement is to expand that discussion and provide more detailed information on conducting such assessments.
Related Products:
Report
Federal Data for Conducting Patient-Centered Outcomes Research on Economic Outcomes
The objective of this report is to assess the current landscape of federal and federally funded health care data relevant to PCOR and economic analysis to identify gaps for data stewards, researchers, and future collection efforts.
Report
Building the Evidence Base for Social Determinants of Health Interventions
In an effort to help build the evidence base around the social determinants of health (SDOH), the Assistant Secretary for Planning and Evaluation (ASPE) engaged RAND in a project to evaluate the current evidence from programs and policies targeting SDOH and identify the SDOH research questions, data sources, and data gaps that might be used to develop an SDOH research agenda.
Report
Status Report on Protecting Our Infants Act Implementation Plan: 2019
In accordance with Section 7062(a) of the SUPPORT Act, in 2019 HHS published the first Status Report on Protecting Our Infants Act Implementation Plan, which included activities through August 2018 on the identification, prevention and treatment of Neonatal Abstinence Syndrome (NAS) and opioid use disorder in pregnant women.
Report
Comprehensive Plan for Addressing High Drug Prices: A Report in Response to the Executive Order on Competition in the American Economy
President Biden’s Executive Order 14036, “Promoting Competition in the American Economy” (the Competition Executive Order), identifies a lack of competition as a key driver for problems across economic sectors.